Adapting to the Changing Life Sciences Landscape: Takeaways from 2023 Informa Connect Access USA Conference (Part 2)
ALLISON CUTTS | Executive Director, Business Development and Sales – Patient Support Solutions]
[Author:
TOM DOUGLAS | Executive Director, Digital Patient Support Solutions]
As we indicated in our last blog, it’s essential to stay informed and up to date on the latest developments in technology, medicine, and patient care. At the recent Informa Connect Access USA conference, some of the best minds in the industry gathered to discuss the challenges posed by the rapidly evolving life sciences field and how to work differently to adapt.
In this blog post, we’ll discuss some of the most important takeaways from the conference and what they mean for life science organizations (LSOs).
Prepare for Evolution
The best-served patients get an individualized patient-centric experience. The healthcare industry has undergone a significant transformation in its approach to patient care. The shift from a product-centric model to a patient-centric model has become increasingly important as healthcare providers strive to provide better care and outcomes for their patients.
The product-centric model of healthcare is a traditional approach that has been used for decades. This approach places the emphasis on the products, treatments, and services that are provided to patients, where healthcare providers tend to focus more on the product, rather than the patient. This means that care is more standardized and is not as personalized to the individual needs of each patient.
Personalized patient-centricity represents an evolution from the product-centric model to a more patient-centered approach. In this approach, healthcare providers focus on the needs and preferences of individual patients. Care is tailored to the unique needs of each patient, and their preferences are taken into consideration when developing treatment plans. Personalized patient-centricity involves the use of technologies such as electronic health records and patient portals to improve communication between patients and their healthcare providers. This model also incorporates patient feedback and experiences to inform and improve the care delivered.
Individualized patient-centricity is the latest evolution in patient care. It represents a shift from personalized care to truly individualized care that is tailored to the unique needs of each patient. This model takes into consideration the individual patient’s medical history, genetic makeup, lifestyle factors, and other unique factors that may impact their health.
The evolution from product-centricity to personalized patient-centricity and ultimately to individualized patient-centricity is an ongoing strategic approach to healthcare. This approach places the patient at the center of care and focuses on delivering personalized and individualized care that meets their unique needs. As the industry continues to embrace this approach, we can expect to see ongoing improvements in patient outcomes, as well as increased patient satisfaction and engagement. The use of advanced technologies will play a significant role in this evolution, enabling healthcare providers to deliver truly individualized care that is tailored to the unique needs of each patient.
Integration and Connectivity
Using integration and connectivity, LSOs can quickly implement the most transformative strategies. There has been a longstanding focus on developing point solutions to address specific challenges or needs. While these solutions may be effective in the short term, they can often create silos of data and impede the ability to fully realize the potential of emerging technologies and new scientific discoveries. To keep pace with the rapidly evolving landscape of healthcare and scientific research, innovative life science organizations should consider moving away from point solutions. By doing so, they can accelerate the most promising strategy and future-proof their investments.
By integrating data and processes across different areas of the organization, teams can work more efficiently and effectively to identify patterns and trends and gain a deeper understanding of the complex relationships between different factors. Connectivity allows cross-platform communication, enabling free data flow to facilitate inter-team collaboration.
LSOs, in particular, benefit from this evolution, where research is becoming increasingly complex and data intensive. By integrating data from multiple sources, such as clinical trials, genomic data, and electronic health records, organizations can gain a more comprehensive and wholistic understanding of the factors that influence health outcomes and disease progression. This can help researchers identify new targets for drug development, design more effective clinical trials, and personalize treatments based on an individual’s unique genetic profile.
In addition, connectivity can help organizations keep pace with the rapid pace of innovation in life sciences. By connecting different systems and platforms, organizations can more easily adopt new technologies and integrate them into their workflows. For example, by integrating electronic health records with wearable devices, organizations can collect real-time data on patients’ health and behavior, which can be used to develop more personalized treatments and interventions.
Moving Beyond Point Solutions
Many LSOs continue to rely on point solutions to address specific challenges or needs. While these solutions may be effective in the short term, they can create silos of data and impede the ability to fully realize the potential of emerging technologies and new scientific discoveries.
Organizations should adopt a more holistic approach that emphasizes integration and connectivity. This may involve investing in platforms that can aggregate data from multiple sources, such as electronic health records, genomic databases, and clinical trials. These platforms should be designed to allow for easy data sharing and collaboration between different care teams and their stakeholders.
In addition, LSOs should prioritize connectivity between different systems and platforms. This may involve adopting open standards and APIs that enable different systems to communicate with one another. By doing so, LSOs can more easily adopt new technologies and integrate them into their workflows, without creating additional silos of data or impeding collaboration between different teams.
Future-Proofing Investments
A more integrated and connected approach helps LSOs future-proof their investments and stay ahead of the curve in a rapidly evolving industry. This enables organizations to more easily adopt new technologies and innovations, accelerate research and development, and develop more personalized treatments and interventions.
To get started, organizations should identify areas of their operations where integration and connectivity can provide the most value. This may involve conducting a comprehensive assessment of their data and technology infrastructure, and identifying areas where there are gaps or opportunities for improvement. From there, organizations can develop a roadmap for adopting new platforms and technologies and begin to implement them in a phased approach.
In conclusion, LSos must move away from point solutions and towards longer-term approaches that emphasize integration and connectivity. By doing so, they can accelerate the most promising and transformative strategies, future-proof their investments, and keep pace with the rapid pace of innovation in the life sciences.
💡 Connect with Allison Cutts or Tom Douglas to learn how Medocity’s patient-centric digital solutions can help your organization to continuously adapt and evolve with changes in regulations, technology, and patient needs, while staying focused on nurturing authentic care and building strategic teams.